Equity
€185,984 ▲ 19.2%
DR. ELS DECROP has made a profit without a break since 2018.
DR. ELS DECROP
Lifetime
17 annual accounts with figures on one time axispeak €61,268 (2021)
€43,480▼ 25.4%
lowest -€11,580 (2010)
€29,923▼ 17.4%
peak €185,984 (2025)
€185,984▲ 19.2%
€8,186▼ 23.4%
Board1 name since 2019
1 directorDECROP Els Marguerite Marie Louise
Documentsfilings and deeds
28-08-202628 days late
2025abbreviated format
Gross margin from €58,319 to €43,480Equity from €156,061 to €185,984Debts from €10,690 to €8,186
Key points
from the 2025 annual accountsFilings
17 annual accounts since 2009
Ten of the last ten came late. The 2020 accounts came latest: 30 days after the end of the period.
Position in the sector
95.8%
Higher solvency than 93% of companies in human health. Sector median 59.2% · 3,053 companies.
Checked score
96
Excellent
Financially stronger than 70% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025highest value
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025lowest value
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
lowers risk
Liquidity: current ratio 22.69, cash €169,381
Sector: Human health activities (NACE 86)
Equity €185,984 (95.8% of total assets)
Size: total assets €194,171
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 41% on profitability and 63% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 34,693 companies had the same profile as DR. ELS DECROP has now. Each dot stands for 87 companies, two years later.
95.3%
were still trading
3.9%
stopped another way
0.7%
went bankrupt
That fits the bankruptcy probability of DR. ELS DECROP itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 34,693 companies, not a prediction for DR. ELS DECROP. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €17,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 22.69 (14.62 in 2024), above the usual 1.5. Short-term debt is 4.2% and cash 87.2% of total assets. 4.2% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 28 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
28 days late
2024
25 days late
2023
29 days late
2022
24 days late
2021
29 days late
2020
30 days late
2019
12 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 25 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 August (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Amendment of the articles · Legal-form change · Resignations & appointments
Change of role: DECROP Els Marguerite Marie Louise, from statutory manager to statutory director · Director discharge: DECROP Els Marguerite Marie Louise · General meeting of 13-04-2023 · Gazette deed
Incorporation
published on 04-03-2009 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DR. ELS DECROP Sint-Katelijne-Waver | €194,171 | €43,480 | 95.8% | - |
| Dr. Sevenants Lieve, pediatrie Aarschot | €195,491 | €42,556 | 81.7% | - |
| TIMALVEOLE Aywaille | €202,423 | €44,639 | 75.6% | - |
| Docteur Gilles CEYSENS Mons | €192,563 | €39,994 | 53.1% | - |
| DOCTEUR COLINET STEPHANIE Chaudfontaine | €182,415 | €46,036 | 69.3% | - |
| DOCTEUR MICHEL Genappe | €217,061 | €42,105 | 91.1% | - |
| J-M BOUTTEFEUX, DOCTEUR Woluwe-Saint-Pierre | €167,644 | €45,828 | 91.5% | - |
These companies have the same main activity as DR. ELS DECROP: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €168,000 and €217,000, founded between 2008 and 2009.
Official details
Source: KBO- Status
- Active since 19-02-2009Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Insights on DR. ELS DECROP
DR. ELS DECROP files the abbreviated format. That format states no turnover. The gross margin rose from €4,325 in 2009 to €43,480 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DR. ELS DECROP
- What is the company number of DR. ELS DECROP?
- The company number of DR. ELS DECROP is 0809.990.184. The VAT number is the same number with BE in front: BE 0809.990.184.
- Where is DR. ELS DECROP based?
- The registered office is at Berlaarbaan 206, 2860 Sint-Katelijne-Waver.Company details
- What does DR. ELS DECROP do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DR. ELS DECROP?
- DR. ELS DECROP is a private limited company (BV).
- When was DR. ELS DECROP founded?
- DR. ELS DECROP was founded on 19-02-2009.
- Is DR. ELS DECROP still active?
- Yes, DR. ELS DECROP is an active enterprise in the KBO register.
- What is the turnover of DR. ELS DECROP?
- The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €43,480 and 62 comparable companies (NACE 86). It probably lies between €95,000 and €180,000.Financials
- Is DR. ELS DECROP profitable?
- In financial year 2025, DR. ELS DECROP made a profit of €29,923.
- Where can I find the annual accounts of DR. ELS DECROP?
- DR. ELS DECROP filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DR. ELS DECROP due?
- DR. ELS DECROP must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.